ADMA Adma Biologics PE ratio, current and historical analysis
As of Feb 21, 2025, the Adma Biologics stock's PE ratio is 54.62. This takes into account the latest EPS of $0.29 and stock price of $15.84.
ADMA PE ratio history
Adma Biologics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $4.52 | -$0.13 |
| 2022 | N/A | N/A | $3.88 | -$0.33 |
| 2021 | N/A | N/A | $1.41 | -$0.51 |
| 2020 | N/A | N/A | $1.95 | -$0.88 |
| 2019 | N/A | N/A | $4 | -$0.89 |
| 2018 | N/A | N/A | $2.39 | -$1.45 |
| 2017 | N/A | N/A | $3.21 | -$1.91 |
| 2016 | N/A | N/A | $5.12 | -$1.61 |
| 2015 | N/A | N/A | $8.07 | -$1.73 |
| 2014 | N/A | N/A | $11.17 | -$1.81 |
| 2013 | N/A | N/A | $7.8 | -$2.38 |
| 2012 | N/A | N/A | N/A | -$1.39 |
| 2011 | N/A | N/A | N/A | -$16.72 |
Adma Biologics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 68.93 | -7.51% | $19.99 | $0.29 |
| Jun 2024 | 74.53 | N/A | $11.18 | $0.15 |
| Mar 2024 | N/A | N/A | $6.6 | -$0.02 |
| Dec 2023 | N/A | N/A | $4.52 | -$0.13 |
| Sep 2023 | N/A | N/A | $3.58 | -$0.11 |
| Jun 2023 | N/A | N/A | $3.69 | -$0.2 |
| Mar 2023 | N/A | N/A | $3.31 | -$0.24 |
| Dec 2022 | N/A | N/A | $3.88 | -$0.33 |
| Sep 2022 | N/A | N/A | $2.43 | -$0.35 |
| Jun 2022 | N/A | N/A | $1.98 | -$0.4 |
| Mar 2022 | N/A | N/A | $1.83 | -$0.48 |
| Dec 2021 | N/A | N/A | $1.41 | -$0.51 |
| Sep 2021 | N/A | N/A | $1.13 | -$0.64 |
| Jun 2021 | N/A | N/A | $1.6 | -$0.7 |
| Mar 2021 | N/A | N/A | $1.76 | -$0.78 |
ADMA average PE ratio chart
ADMA PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| ADMA Adma Biologics Inc | 54.62 | $3.74B |
| NVAX Novavax Inc | N/A | $1.28B |
| RGEN Repligen Corp | N/A | $8.91B |
| CVM Cel Sci Corp | N/A | $30.58M |
Frequently asked questions
What is Adma Biologics's PE ratio?
ADMA's price to earnings ratio is 54.62 as of Feb 21, 2025.
How is ADMA's PE ratio calculated (Adma Biologics PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Feb 21, 2025), Adma Biologics's share price is $15.84. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.29. Therefore, Adma Biologics's PE ratio for today is 54.62. PE RATIO(54.62) = STOCK PRICE($15.84) / TTM EPS($0.29)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.